Get Premium to unlock powerful stock data
Astria Therapeutics Inc logo

Astria Therapeutics Inc

$ 4.14 +0.12 (+2.99%) 10:08 PM EST
P/E:
At Loss
P/B:
2.05
Market Cap:
$ 53.89M
Enterprise V:
$ 23.58M
Volume:
11.34K
Avg Vol (2M):
15.18K
Also Trade In:
Volume:
11.34K
Market Cap $:
53.89M
PE Ratio:
At Loss
Avg Vol (2-Month):
15.18K
Enterprise Value $:
23.58M
PB Ratio:
2.05
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Astria Therapeutics Inc
NAICS : 325412 SIC : 2834
100 High Street, 28th Floor, Boston, MA, USA, 02110
Description
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.
Name Current Vs Industry Vs History
Cash-To-Debt 343.86
Equity-to-Asset 0.96
Debt-to-EBITDA -0.01
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -3.54
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 22.94
9-Day RSI 22.49
14-Day RSI 26.21
6-1 Month Momentum % -6.7
12-1 Month Momentum % -40.65

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 24.42
Quick Ratio 24.42
Cash Ratio 24.12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -122

Financials (Next Earnings Date:2022-08-09 Est.)

ATXS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ATXS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -52.279
Beta 1.2
Volatility % 54.42
14-Day RSI 26.21
14-Day ATR ($) 0.448664
20-Day SMA ($) 5.40041
12-1 Month Momentum % -40.65
52-Week Range ($) 3.83 - 15.719968
Shares Outstanding (Mil) 13.02

Piotroski F-Score Details

Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Astria Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More